secwatch.observer — SEC 8-K summary
======================================

Issuer:     CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CIK:        0001187953
Form:       8-K
Filed at:   2021-12-07T23:59:59+00:00
Accession:  0001477932-21-009015
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Creative Medical Technology Holdings prices $16M public offering, uplists to Nasdaq, appoints new directors
--------------------------------------------------------------------------------

- Priced 3.875M shares and warrants at $4.13 per combined unit; gross proceeds ~$16M.
- Common stock begins trading on Nasdaq Capital Market under ticker CELZ as of Dec 3, 2021.
- Thomas Ichim and Amit Patel resigned as directors; Michael Finger, Susan Snow, Bruce Urdang appointed.
- Proceeds to redeem $5.1M in senior notes, repurchase ~$195k of Series A preferred from CEO, fund clinical trials.
- Underwriter Roth Capital granted 45-day option for up to 581,250 additional shares/warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1187953/000147793221009015/0001477932-21-009015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1187953/000147793221009015/celz_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-21-009015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer